Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06014164
Other study ID # RC31/23/0396
Secondary ID 2023-A01575-40
Status Not yet recruiting
Phase
First received
Last updated
Start date November 30, 2023
Est. completion date March 10, 2025

Study information

Verified date November 2023
Source University Hospital, Toulouse
Contact Antoine YRONDI, MD
Phone 0561778603
Email yrondi.a@chu-toulouse.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 25
Est. completion date March 10, 2025
Est. primary completion date March 10, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner - Patients used psychedelic or related substances in order to treat psychiatric symptoms - Patients have given their oral non-opposition - Patients affiliated to a social security scheme Exclusion Criteria: - Patients who don't speak or understand French - Patients under protection, guardianship or curators

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Interview
An interview will be conducted to describe the experiences of people with psychiatric disorders who use psychedelic substances for therapeutic purposes

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Outcome

Type Measure Description Time frame Safety issue
Primary Experiences of people using psychedelic substances Experiences description of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview Baseline
Secondary Profile of people using psychedelic substances The profile of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview Baseline
See also
  Status Clinical Trial Phase
Completed NCT03409991 - Testing the Efficacy of Opening Doors: A Career Guidance Intervention for Individuals With Psychiatric Disabilities N/A
Not yet recruiting NCT05316948 - Mental Health and Sexuality in Adolescents and Young Adults
Completed NCT04778163 - The Use of Humor With Young Adults in Psychiatric Care N/A
Not yet recruiting NCT06304363 - Braining - Evaluation of Acute Effects of Physical Exercise N/A
Recruiting NCT04096625 - Enhancement of a Psychotherapeutic Intervention Through Transcranial Direct Current Stimulation (tDCS) N/A
Not yet recruiting NCT05930353 - Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
Terminated NCT06012981 - Psychological Treatment in Psychiatric Inpatient Care N/A
Completed NCT04099173 - A Brief Mindfulness-Based Intervention for Suicidal Ideation N/A
Completed NCT01866956 - Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders
Recruiting NCT04249960 - Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study. N/A
Recruiting NCT05962424 - HNC: Human Neural Circuits Electrophysiology During Cognition Phase 1
Recruiting NCT06092866 - Digital Versus Telephone Symptom Assessment and Triage in Primary Care N/A
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Completed NCT03748355 - Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects N/A
Completed NCT05473962 - Mid-Term Follow-up Assessment After Exposure to Natural Disaster
Recruiting NCT05577585 - Ketamine and Stress in OCD N/A
Completed NCT05124158 - COVID-19 Severity and Psychiatric Morbidity
Recruiting NCT05560581 - Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy N/A
Completed NCT04618250 - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) N/A
Active, not recruiting NCT05219357 - Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis Situations N/A